Nancy C Carrico

Title: Nancy C. Carrico: Innovator in Viral-Based Expression Systems

Introduction

Nancy C. Carrico is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of biotechnology, particularly in the development of viral-based expression systems. With a total of 3 patents to her name, her work has paved the way for advancements in molecular production.

Latest Patents

One of her latest patents is titled "Recombinant arterivirus replicon systems and uses thereof." This patent focuses on viral-based expression systems that are suitable for producing molecules of interest in recombinant host cells. The disclosure relates to nucleic acid constructs, such as expression vectors, that contain a modified arterivirus genome or replicon RNA. In this system, some of the original viral sequences have been deleted. Additionally, the patent includes viral-based expression vectors that feature one or more expression cassettes encoding heterologous polypeptides. These expression cassettes are strategically configured and positioned on the viral genome to enable tunable expression of the heterologous polypeptides.

Career Highlights

Nancy C. Carrico is currently associated with Janssen Pharmaceuticals, Inc., where she continues to innovate in her field. Her work has been instrumental in advancing the understanding and application of viral expression systems in biotechnology.

Collaborations

Throughout her career, Nancy has collaborated with notable colleagues, including Kurt Iver Kamrud and Nathaniel Stephen Wang. These collaborations have further enhanced her research and contributions to the field.

Conclusion

Nancy C. Carrico is a trailblazer in the realm of viral-based expression systems, with her innovative patents and collaborations significantly impacting biotechnology. Her work continues to inspire advancements in molecular production and expression technologies.